International Patent: RISK LEVEL OF REDUCTION OF PROTEINS EXPRESSED AND PRODUCED BY CULTURED CELLS DURING STANDING OF HARVESTED CELL CULTURE FLUID, AND INHIBITION THEREOF

GENEVA, Sept. 18 -- WUXI BIOLOGICS CO., LTD. filed a patent application (CN2026/081253) for “RISK LEVEL OF REDUCTION OF PROTEINS EXPRESSED AND PRODUCED BY CULTURED CELLS DURING STANDING OF HARVESTED CELL CULTURE FLUID, AND INHIBITION THEREOF”. With publication no. WO/2026/184611, here are the other details related to the patent application:

Kind: Initial Publication with ISR [A1]

IPC: G01N 27/447

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Disclaimer: Curated by HT Syndication....